Spinal Cord Oligodendrocyte Precursor Cells In Neurodegeneration is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Oligodendrocyte precursor cells (OPCs), also known as NG2-positive glia, are distributed throughout the central nervous system and are responsible for myelinating axons. These cells have emerged as important players in neurodegenerative diseases, both for their remyelination potential and their involvement in disease progression.
¶ Distribution and Properties
- Location: Throughout gray and white matter of spinal cord
- Marker expression: NG2 (chondroitin sulfate proteoglycan), PDGFRA, Olig2
- Proliferation capacity: High regenerative potential
- Differentiation: Can mature into myelinating oligodendrocytes
OPCs in ALS show:
- Proliferation defects: Reduced OPC division in affected regions
- Differentiation failure: Inability to generate mature oligodendrocytes
- Contribution to disease: May exacerbate axonal degeneration
While not purely neurodegenerative:
- Remyelination failure: OPCs fail to differentiate in chronic lesions
- Demyelination: Progressive loss of myelin
- Axonal loss: Secondary to demyelination
- Reactive OPCs: Form glial scars
- Remyelination attempts: Often unsuccessful in chronic injury
- Neuronal support: Alterations in neuronal survival mechanisms
| Pathway |
Role |
Dysfunction in Disease |
| PDGF |
OPC proliferation |
Reduced signaling |
| LIF |
Survival signals |
Altered in ALS |
| Wnt |
Differentiation |
Inhibited in MS |
- Metabolic support: Provide lactate to axons
- Ionic homeostasis: Potassium buffering
- Trophic factors: Secretion of neurotrophins
- Cell transplantation: OPC/OLP transplantation trials
- Pharmacological activation: Promoting OPC differentiation
- Gene therapy: Enhancing OPC function
- NG2 levels in CSF
- Imaging of OPC populations
- Myelin-related metabolites
The study of Spinal Cord Oligodendrocyte Precursor Cells In Neurodegeneration has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- OPCs in amyotrophic lateral sclerosis
- Oligodendrocyte lineage in neurodegeneration
- Remyelination failure in disease